The Biotech Growth Trust PLC
BIOG.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | £71 | -£86 | £10 | £91 |
| % Growth | 182.4% | -931.3% | -88.6% | – |
| Cost of Goods Sold | £1 | £1 | £0 | £3 |
| Gross Profit | £0 | £0 | £10 | £88 |
| % Margin | 0% | -0% | 100% | 96.4% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £2 | £2 |
| SG&A Expenses | £0 | £0 | £2 | £2 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £2 | £2 |
| Operating Income | £70 | -£88 | £8 | £89 |
| % Margin | 97.9% | 101.9% | 80.4% | 97.8% |
| Other Income/Exp. Net | -£0 | -£3 | -£0 | -£0 |
| Pre-Tax Income | £69 | -£91 | £8 | £88 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | £69 | -£91 | £8 | £88 |
| % Margin | 97.5% | 105.1% | 78.1% | 97.3% |
| EPS | 2.73 | -2.87 | 0.25 | 2.55 |
| % Growth | 195.1% | -1,248% | -90.2% | – |
| EPS Diluted | 2.73 | -2.87 | 0.25 | 2.44 |
| Weighted Avg Shares Out | 25 | 32 | 33 | 35 |
| Weighted Avg Shares Out Dil | 25 | 32 | 33 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £177 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | -£8 | -£89 |
| EBITDA | £70 | -£88 | £8 | £0 |
| % Margin | 97.9% | 101.9% | 80.4% | 0% |